The Hyderabad-based generics maker is now India’s largest supplier of off-patent medicines to the US.
You can always update your display preferences in Settings menu
On 3 June, Aurobindo Pharma Ltd announced its annual results. It had turned in a stellar performance, with an all-round improvement in sales and profits. And, on 10 August, its stock raced past Rs 950, the highest level in a decade. But one highlight went almost unnoticed.
In fiscal year 2020, the company’s US sales totted up to $1,622 million, making it the top pharmaceuticals supplier to the lucrative American market and ousting Sun Pharmaceutical Industries Ltd, which notched up $1,487 million, from the top slot.
No small achievement this, considering Aurobindo Pharma’s ascension to the top of the exporters’ club makes it only the third company to grab the spot after Ranbaxy Laboratories Ltd, which held the position until it was merged with Sun Pharma in 2015.
So why is this such a big deal? The US pharmaceutical market is also the world’s largest and consequently the biggest for generic drugs, medicines whose patents have expired and can be replicated.
Sign up to claim your 10 free starter credits and unlock the story.
Already have an account with TMC?
Sign in
SIGN UP
Everything you need to know. Only with TMC.
The Morning Context’s mission is to build an independent, credible media company, which tells stories that matter. On the internet, business and chaos.
We ensure that our stories has an original point of view, covers new ground in critical analysis of the business, is an investigation into why something happened and makes sense of the complex world around us. Check out what else we have to offer.
Why choose
TMC?
Information and analysis you won’t find anywhere else
Read in-depth explainers, stories of startup battles and honest, genuine interviews.
Independent and unbiased journalism
We’re not afraid to write hard-hitting stories—we serve you, the reader.
Premium newsletters
Get insights from some of the best writers in India right in your inbox.
TMC Dialogues
Be a part of our exclusive subscriber community and discussions.
Get all the news from our categories
Reader’s quotes
What our reader’s love about TMC.
Research ideas don't come from a vacuum. The best ideas come from a spark, a contrarian take, an uncommon investigative insight, and one doesn't always get these from traditional media. TMC consistently makes me think about things in different ways, and I've frequently shared TMC articles with collaborators and students. Staying at the cutting edge is hard enough; TMC makes it much easier.
Rohit Chandra, Assistant Professor - School of Public Policy (IIT Delhi)
High quality, independent journalism is rare to find. The Morning Context set really high standards that make me wait for each story.
Abhay Pandey, Managing partner, A91 Capital
Well-written and researched long form reads on a wide variety of topics and a team of veteran journalists - all of this makes my subscription worth it.
Anupam Gupta, Investment research consultant
In today's very noisy and cluttered world, I like that the Morning Context goes below the surface of company PR to deliver fact-based stories on Indian business.
Jessie Paul, CEO, Paul Writer
The Morning Context is my daily opportunity to get smarter about one new company/sector. Discerning analysis, unbiased and approachable.
Miten Sampat, Angel investor & former CSO, Times Internet
In today's polarized world, authentic and unbiased facts are in short supply world over. The Morning Context is a refreshing approach towards truthful, well researched, fearless, and high-quality articles on contemporary topics.
N S Parthasarthy, Co-founder, Mindtree
In a world full of noise, The Morning Context is the calm that stimulates and energises your mind, with stories focused on fact, truth and dogged reportage.
Nikhil Taneja, Co-founder and CEO, Yuvaa
Although it’s a paid subscription, the kind of detailed research and quality of reportage makes it worth every rupee. It’s strength surely lies in having some of the finest journalists writing for it.
Shiladitya Bora, Producer, distributor and founder at Platoon One Films
As one of the early subscribers, I've had the opportunity to witness how quickly the team has grown, the variety of angles covered, and the research in every in-depth story and op-ed.
Amarjit Batra, Managing director, Spotify India
BACK TO TOP
More questions? Let us help
Contact us
Context is everything Only read stories that matter.
the morning context
©2021 Slowform Pte Limited
68 Circular Road, #02-01, 049422, Singapore